Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting

BACKGROUND: Diverging approaches towards market entry and uptake of biosimilars, even within a country, leads to regional variation in biosimilar use. This is the case in Sweden, where the 21 county councils control the healthcare budget and offer regional guidance. OBJECTIVES: This study aimed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moorkens, Evelien, Simoens, Steven, Troein, Per, Declerck, Paul, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533216/
https://www.ncbi.nlm.nih.gov/pubmed/30945206
http://dx.doi.org/10.1007/s40259-019-00346-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533216/
https://www.ncbi.nlm.nih.gov/pubmed/30945206
http://dx.doi.org/10.1007/s40259-019-00346-5

Ejemplares similares